Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Outcomes after combination photodynamic therapy and immunosuppression for inflammatory subfoveal choroidal neovascularisation Hogan A; Behan U; Kilmartin DJBr J Ophthalmol 2005[Sep]; 89 (9): 1109-11AIM: To report the visual and angiographic outcomes after combination photodynamic therapy (PDT) and immunosuppression for inflammatory subfoveal choroidal neovascularisation (CNV). METHODS: Retrospective review of six consecutive patients, five female and one male, aged 23-40 years with active subfoveal CNV secondary to posterior uveitis. Patients received either intravitreal triamcinolone or systemic immunosuppression (mycophenolate mofetil, tacrolimus) and PDT. Five patients had intravitreal triamcinolone injections and two patients were on systemic immunosuppression; all patients underwent PDT (mean two treatments). Visual acuity was measured on a 2 metre ETDRS chart and fluorescein angiograms were performed at each visit. RESULTS: Median follow up was 15 months (range 10-31). Vision improved by a median of 13 letters in five patients and remained stable (+/-1 letter) in one patient. Median visual acuity improved from 20/160 at presentation to 20/40 at latest follow up (p=0.03). There was a reduction in clinical exudation and cessation of angiographic leakage in all six patients. All interventions were well tolerated. CONCLUSION: Combination PDT and immunosuppression may be a useful therapeutic option for young patients with active inflammatory subfoveal CNV.|*Immunosuppression Therapy[MESH]|*Photochemotherapy[MESH]|Adult[MESH]|Anti-Infective Agents/therapeutic use[MESH]|Choroidal Neovascularization/*drug therapy[MESH]|Combined Modality Therapy[MESH]|Female[MESH]|Fluorescein Angiography[MESH]|Follow-Up Studies[MESH]|Humans[MESH]|Immunosuppressive Agents/therapeutic use[MESH]|Male[MESH]|Mycophenolic Acid/analogs & derivatives/therapeutic use[MESH]|Retrospective Studies[MESH]|Tacrolimus/therapeutic use[MESH]|Treatment Outcome[MESH]|Triamcinolone/therapeutic use[MESH]|Visual Acuity[MESH] |